4//SEC Filing
Geller Matthew 4
Accession 0001062993-11-002347
CIK 0000875622other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 6:31 PM ET
Size
7.9 KB
Accession
0001062993-11-002347
Insider Transaction Report
Form 4
Geller Matthew
Director
Transactions
- Sale
Common Stock
2011-05-23$24.00/sh−1,900$45,600→ 17,700 total - Sale
Common Stock
2011-05-19$24.18/sh−400$9,671→ 29,600 total - Sale
Common Stock
2011-05-20$24.01/sh−10,000$240,054→ 19,600 total
Footnotes (2)
- [F1]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $24.15 to $24.21. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $24.00 to $24.08. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeother
Related Parties
1- filerCIK 0001446201
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 6:31 PM ET
- Size
- 7.9 KB